Assessment of the efficacy and tolerance of an innovative regenerative serum on cutaneous regeneration, following fractional laser procedure using Erbium: YAG
Journal of Cosmetic Dermatology May 01, 2018
Jiménez N, et al. - Reachers ascertained the efficacy and safety of a regenerative serum (Matricium, Laboratoire Bioderma, France) after laser procedure. Data demonstrated that cutaneous regeneration on both the clinical and histological level was accelerated and improved by the use of the regenerative serum after fractional laser on the face and the benefits of the laser procedure were maximized. On histological examinations, experts noted that compared to placebo, a superior thickness of epidermis and higher cellular proliferation rate (Ki67 markers), as well as a superior thickness of dermis with higher increase in elastin density with the regenerative serum was seen.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries